Status:
COMPLETED
Flow-controlled Ventilation (FCV) in Moderate Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19
Lead Sponsor:
University Hospital, Antwerp
Conditions:
COVID-19 Acute Respiratory Distress Syndrome
Respiration, Artificial
Eligibility:
All Genders
18-80 years
Brief Summary
Flow controlled ventilation (FCV) is a fairly new mode of mechanical ventilation, consisting of a constant inspiratory and expiratory flow. Inspiration is thus comparable to volume controlled ventilat...
Eligibility Criteria
Inclusion
- P/F-ratio: 100-200 (moderate ARDS)
- SpO2 88-94%
- PaO2 60-80 mmHg
- COVID-19 positive on a PCR test
Exclusion
- BMI \> 40 kg/m²
- Prone ventilation
- Already invasively mechanically ventilated for more than 10 days
- Refusal to participate
Key Trial Info
Start Date :
January 11 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2021
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT04894214
Start Date
January 11 2021
End Date
May 1 2021
Last Update
February 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Antwerp University Hospital
Edegem, Antwerp, Belgium, 2650